Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort
The Journal of Prevention of Alzheimer's Disease · 2024-10 · 11 (5) · 1480-1489
DOI: 10.14283/jpad.2024.103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Prevention of Alzheimer's Disease, 2024-10. Verfasst von S A Lott und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sarah Averill Lott, Digital Medicine Society (DiMe), Boston, MA, USA, sarah.lott@dimesociety.org, 970-408-0780. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Digitalisierung in der Pflege, Demenz
Abstract (Originalsprache)
Digital health technologies offer valuable advantages to dementia researchers and clinicians as screening tools, diagnostic aids, and monitoring instruments. To support the use and advancement of these resources, a comprehensive overview of the current technological landscape is essential. A multi-stakeholder working group, convened by the Digital Medicine Society (DiMe), conducted a landscape review to identify digital health technologies for Alzheimer's disease and related dementia populations. We searched studies indexed in PubMed, Embase, and APA PsycInfo to identify manuscripts published between May 2003 to May 2023 reporting analytical validation, clinical validation, or usability/feasibility results for relevant digital health technologies. Additional technologies were identified through community outreach. We collated peer-reviewed manuscripts, poster presentations, or regulatory documents for 106 different technologies for Alzheimer's disease and related dementia assessment covering diverse populations such as Lewy Body, vascular dementias, frontotemporal dementias, and all severities of Alzheimer's disease. Wearable sensors represent 32% of included technologies, non-wearables 61%, and technologies with components of both account for the remaining 7%. Neurocognition is the most prevalent concept of interest, followed by physical activity and sleep. Clinical validation is reported in 69% of evidence, analytical validation in 34%, and usability/feasibility in 20% (not mutually exclusive). These findings provide clinicians and researchers a landscape overview describing the range of technologies for assessing Alzheimer's disease and related dementias. A living library of technologies is presented for the clinical and research communities which will keep findings up-to-date as the field develops.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sarah Averill Lott, Digital Medicine Society (DiMe), Boston, MA, USA, sarah.lott@dimesociety.org, 970-408-0780.
Zitieren
APA
Lott, S. A., Streel, E., Bachman, S. L., Bode, K., Dyer, J., Fitzer-Attas, C., Goldsack, J. C., Hake, A., Jannati, A., Fuertes, R. S., & Fromy, P. (2024). Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort. The Journal of Prevention of Alzheimer's Disease, 11(5), 1480-1489. https://doi.org/10.14283/jpad.2024.103
Vancouver
Lott SA, Streel E, Bachman SL, Bode K, Dyer J, Fitzer-Attas C, et al. Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort. The Journal of Prevention of Alzheimer's Disease. 2024;11(5):1480-1489. doi:10.14283/jpad.2024.103
BibTeX
@article{Lott2024,
author = {Lott, S A and Streel, E and Bachman, S L and Bode, K and Dyer, J and Fitzer-Attas, C and Goldsack, J C and Hake, A and Jannati, A and Fuertes, R S and Fromy, P},
title = {Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort},
journal = {The Journal of Prevention of Alzheimer's Disease},
year = {2024},
volume = {11},
number = {5},
pages = {1480--1489},
doi = {10.14283/jpad.2024.103}
}
EUVIMED